Navigation Links
MacuCLEAR, Inc. Raises More Than $1M in Financing and Enters into Strategic Pacific Rim Partnership

with potential investors and partners to further discuss company updates during the JP Morgan Healthcare Conference 2012 being held in San Francisco, CA, January 9-12, 2012.

About MacuCLEAR, Inc.
MacuCLEAR, Inc. is a clinical-stage specialty pharmaceutical company focused on developing innovative treatments for vascular and retinal diseases of the eye.  Its lead compound MC-1101 is a novel, topically delivered eye drop drug for treating and stopping the progression of age-related macular degeneration (AMD) from the early-stage (Dry AMD) to the late-stage (Wet AMD) by improving ocular blood flow.

The active ingredient of MC-1101 has been previously approved by the FDA as an oral antihypertensive drug.  MC-1101 has been granted 505 (b) 2 status and has formal Fast Track designation by the FDA.  In addition to MC-1101, MacuCLEAR's portfolio includes 11 compounds that are being developed for diabetic retinopathy, second-generation treatment for AMD and other vascular diseases of the eye.

George C.Y. Chiou, Ph.D., who led the development of Timolol, a pioneering treatment for glaucoma, invented this technology at Texas A&M University.

Founded in 2006, MacuCLEAR is a privately held Plano, TX-based company.  For additional information, please visit

About Age-Related Macular Degeneration
AMD is the leading cause for blindness in the world in people 50 and older.  Dry AMD afflicts 90 percent of AMD sufferers and currently has no approved drug treatments. 

Media Contact:
Tiberend Strategic Advisors, Inc.
(212) 827-0020
Andrew Mialach,
Claire Sojda,


Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cohera Medical Raises Over $25 Million in Series C Round
2. ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease
3. arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round
4. Vista Partners Updates Coverage on Cellmid Limited; Raises Target Price to AUD $0.12
5. Bayer Virtual Walk for Hemophilia Raises Awareness and Funds for People With Bleeding Disorders
6. NxStage Reports Record Third Quarter 2011 Financial Results and Raises Revenue Guidance For 2011
7. FRC Praises House Committee for Holding Hearing on Conscience-Violating Obamacare Contraceptive Mandate
8. Perrigo Reports Record Quarterly Revenue and Adjusted Earnings and Raises Full Year Adjusted EPS Guidance
9. goBalto Raises Series A Financing to Advance Cloud-based Health Technologies
10. Grateful Weight Loss Patient Praises Micro Gastric Sleeve Surgery
11. CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million
Post Your Comments:
(Date:10/25/2014)... 24, 2014  America,s future engineers will connect ... at the  Medical Design and Manufacturing (MD&M) Minneapolis ... at the Minneapolis ... built robots from the "For Inspiration and Recognition ... and mentors will offer information to those curious ...
(Date:10/25/2014)... 2014  The National Association of Drug Diversion ... by Kentucky,s real-time, stop-sale ... National Precursor Log Exchange (NPLEx) system automatically blocks ... and helps flag meth offenders for law enforcement. ... NPLEx "watch lists" that notify them via email ...
(Date:10/25/2014)... Oct. 24, 2014 In conjunction with DURECT ... financial results press release, you are invited to listen ... over the internet on Monday, November 3, 2014 at ... A live audio webcast of the presentation will ... and clicking "Investor Relations."  If you are unable ...
Breaking Medicine Technology:Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 2Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 3Kentucky's NPLEx Technology Making Significant Progress 2DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2
(Date:10/25/2014)... Mesothelioma researchers are reporting extended survival in ... after his combination drug therapy became too toxic. ... posted on the Surviving Mesothelioma website. , A ... Japan suggests that “maintenance therapy” with pemetrexed may be ... tolerate higher doses of cisplatin. , “Although the ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 ... -- herpes simplex -- might increase the risk of Alzheimer,s ... being a carrier of certain antibodies to the virus can ... "The identification of a treatable cause [herpes simplex] of ... researcher Dr. Hugo Lovheim, an associate professor in the department ...
(Date:10/25/2014)... News) -- A large influx of international aid is ... tens of thousands of deaths from the widening Ebola ... Using a specially designed mathematical model, the researchers ... just one densely populated county of hard-hit Liberia -- ... The researchers said that if international aid isn,t ...
(Date:10/25/2014)... (HealthDay News) -- October,s shorter, darker days can trigger ... according to an expert. People affected by ... tired, lack motivation and even have trouble getting out ... suicide, said Dr. Angelos Halaris, a professor in the ... Chicago Stitch School of Medicine. "Seasonal affective disorder ...
(Date:10/22/2014)... 22, 2014 On October 22, CBS ... featuring skin diseases both fictional and real. The ... nonprofit organization committed to advocacy and philanthropy in the ... take the opportunity to impart truth and clarity about ... There are many misconceptions about Morgellons Disease ...
Breaking Medicine News(10 mins):Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3
... due to use of drugs in northeastern states, Minister ... effective monitoring // and reporting systems in the region ... establish effective drug use monitoring and reporting systems for ... releasing a monograph on the drug use in the ...
... have insurance in the U.S. This shows an increase in ... These individuals between the ages of 19 and 29 are the ... and Rite of Passage neither can figure the reason for no ... not insured at double the rate of adults between 30 – ...
... hospital here, who have been abstaining from duty for ... to introduce reservation in higher education institutions, today went ... whose stir has disrupted medical services in the Swaroop ... hunger strike which they have vowed to continue unless ...
... is usually used to treat insomnia. ,The effects ... of six months by South African researchers//. Neurological rehabilitation experts ... open, awake but unaware of the surroundings, no interaction and ... state. ,Zolpidem was given to the patients ...
... of a woman suffering from domestic violence getting in ... department about the topic. This approach however does not ... reveals a study, published in Archives of Internal Medicine, ... issues prevents many physicians from identifying victims of domestic ...
... U.S. have given an approval for the drug Remicade ... which is a chronic// and debilitating condition. ... that causes diarrhea, fever, abdominal pain, weight loss and, ... it can involve any area of the gastrointestinal tract ...
Cached Medicine News:Health News:No Insurance For Young Adults In U.S. 2Health News:No Insurance For Young Adults In U.S. 3Health News:Discussion On Domestic Violence Increased By Computer Based Screening 2Health News:Discussion On Domestic Violence Increased By Computer Based Screening 3Health News:Arthritic Drug Approved For Use In Children With Crohn’s Diseas 2
... Leica M844 F40 with its new stand F19 ... allow on the one hand to homogenously move ... operate with a solid and stable microscope. The ... Chrome optics, stands on the same small footprint ...
... 2000 assays are designed ... IMMULITE 2000, a high-throughput, ... analyzer. IMMULITE 2000 offers ... and a rapidly expanding ...
... Detection Of Serum C-Peptide ... Measurement:, Evaluating patients ... Assisting in the classification ... Differentiating insulin dependent patients ...
Medicine Products: